Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Establishment Labs particpiates in a conference call hosted by Stephens » 10:55
06/23/20
06/23
10:55
06/23/20
10:55
ESTA

Establishment Labs

$16.93 /

-0.88 (-4.94%)

Stephens holds a…

Stephens holds a conference call with CEO Quiros and CFO Gaeta on June 23 at 11 am.

ShowHide Related Items >><<
ESTA Establishment Labs
$16.93 /

-0.88 (-4.94%)

ESTA Establishment Labs
$16.93 /

-0.88 (-4.94%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
ESTA Establishment Labs
$16.93 /

-0.88 (-4.94%)

Conference/Events
Establishment Labs particpiates in a conference call hosted by Stephens » 09:04
06/19/20
06/19
09:04
06/19/20
09:04
ESTA

Establishment Labs

$17.69 /

-0.49 (-2.70%)

Stephens holds a…

Stephens holds a conference call with CEO Quiros and CFO Gaeta on June 23 at 11 am.

ShowHide Related Items >><<
ESTA Establishment Labs
$17.69 /

-0.49 (-2.70%)

ESTA Establishment Labs
$17.69 /

-0.49 (-2.70%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
ESTA Establishment Labs
$17.69 /

-0.49 (-2.70%)

Over a month ago
Hot Stocks
Establishment Labs receives CE Mark for Motiva Flora Tissue Expander » 08:15
06/11/20
06/11
08:15
06/11/20
08:15
ESTA

Establishment Labs

$18.25 /

-1.08 (-5.59%)

Establishment Labs…

Establishment Labs announced it has received CE Mark for the Motiva Flora Tissue Expander. The Motiva Flora Tissue Expander, with its proprietary SmoothSilk surface, is the only such product with an integrated RFID port with no magnets, allowing for use of the expander safely alongside MRI scanning. Recently published research1 concluded that Flora offers potential advantages for patients undergoing MRI compared with tissue expanders that have magnetic ports that create substantial signal losses and distortion on MR images. Motiva Flora and Motiva Implants offer the SmoothSilk surface, a bioengineered nanosurface that has demonstrated a very low rate of capsular contracture and no reported cases of BIA-ALCL to date. Establishment Labs intends to extend its presence into the reconstruction market with the introduction of its Flora tissue expander alongside Motiva Implants. The Company expects to immediately commence pre-marketing activities in Europe for Flora in preparation for a broad commercial launch in early 2021.

ShowHide Related Items >><<
ESTA Establishment Labs
$18.25 /

-1.08 (-5.59%)

ESTA Establishment Labs
$18.25 /

-1.08 (-5.59%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
ESTA Establishment Labs
$18.25 /

-1.08 (-5.59%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/20/20
05/20
04:55
05/20/20
04:55
RDHL

RedHill Biopharma

$7.19 /

+0.28 (+4.05%)

, ANGO

AngioDynamics

$11.05 /

+0.11 (+1.01%)

, CDXS

Codexis

$11.15 /

-0.42 (-3.63%)

, AHCO

AdaptHealth

$16.68 /

+0.18 (+1.09%)

, APLT

Applied Therapeutics

$47.53 /

+2.41 (+5.34%)

, TFX

Teleflex

$346.33 /

-6.665 (-1.89%)

, UHS

Universal Health

$101.01 /

+0.55 (+0.55%)

, HRC

Hill-Rom

$98.94 /

-2.17 (-2.15%)

, NVRO

Nevro

$122.31 /

+0.47 (+0.39%)

, AMED

Amedisys

$190.01 /

-2.98 (-1.54%)

, ESTA

Establishment Labs

$16.25 /

-0.86 (-5.03%)

, HUM

Humana

$395.51 /

+4.41 (+1.13%)

, VKTX

Viking Therapeutics

$7.05 /

-0.09 (-1.26%)

, WST

West Pharmaceutical

$211.46 /

-7.14 (-3.27%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.15 /

-0.42 (-3.63%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$346.33 /

-6.665 (-1.89%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$101.01 /

+0.55 (+0.55%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$122.31 /

+0.47 (+0.39%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$190.01 /

-2.98 (-1.54%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$395.51 /

+4.41 (+1.13%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/19/20
05/19
04:55
05/19/20
04:55
RDHL

RedHill Biopharma

$6.91 /

+0.18 (+2.67%)

, ANGO

AngioDynamics

$10.94 /

+0.93 (+9.29%)

, CDXS

Codexis

$11.57 /

+0.47 (+4.23%)

, AHCO

AdaptHealth

$16.50 /

+0.21 (+1.29%)

, APLT

Applied Therapeutics

$45.12 /

+1.22 (+2.78%)

, TFX

Teleflex

$353.00 /

+18.395 (+5.50%)

, UHS

Universal Health

$100.46 /

+7.86 (+8.49%)

, HRC

Hill-Rom

$101.11 /

+1.3 (+1.30%)

, NVRO

Nevro

$121.84 /

+4.09 (+3.47%)

, AMED

Amedisys

$192.99 /

+8.12 (+4.39%)

, ESTA

Establishment Labs

$17.11 /

+0.71 (+4.33%)

, HUM

Humana

$391.10 /

-7.25 (-1.82%)

, VKTX

Viking Therapeutics

$7.14 /

+0.04 (+0.56%)

, WST

West Pharmaceutical

$218.60 /

+4.73 (+2.21%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.57 /

+0.47 (+4.23%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$353.00 /

+18.395 (+5.50%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$100.46 /

+7.86 (+8.49%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$121.84 /

+4.09 (+3.47%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$192.99 /

+8.12 (+4.39%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$391.10 /

-7.25 (-1.82%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

Conference/Events
UBS to hold a virtual conference » 08:53
05/18/20
05/18
08:53
05/18/20
08:53
RDHL

RedHill Biopharma

$6.73 /

-0.11 (-1.61%)

, ANGO

AngioDynamics

$10.01 /

+0.01 (+0.10%)

, CDXS

Codexis

$11.10 /

+0.35 (+3.26%)

, AHCO

AdaptHealth

$16.29 /

-0.11 (-0.67%)

, APLT

Applied Therapeutics

$43.90 /

+0.85 (+1.97%)

, TFX

Teleflex

$334.60 /

+1.41 (+0.42%)

, UHS

Universal Health

$92.60 /

+1.13 (+1.24%)

, HRC

Hill-Rom

$99.81 /

+0.4 (+0.40%)

, NVRO

Nevro

$117.75 /

-2.27 (-1.89%)

, AMED

Amedisys

$184.87 /

+7.66 (+4.32%)

, ESTA

Establishment Labs

$16.40 /

-0.91 (-5.26%)

, HUM

Humana

$398.35 /

+12.43 (+3.22%)

, VKTX

Viking Therapeutics

$7.10 /

+0.2 (+2.90%)

, WST

West Pharmaceutical

$213.87 /

+3.45 (+1.64%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.10 /

+0.35 (+3.26%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$334.60 /

+1.41 (+0.42%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$92.60 /

+1.13 (+1.24%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$117.75 /

-2.27 (-1.89%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$184.87 /

+7.66 (+4.32%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$398.35 /

+12.43 (+3.22%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

Initiation
Fly Intel: Top five analyst initiations » 10:04
05/14/20
05/14
10:04
05/14/20
10:04
NFLX

Netflix

$443.62 /

+4.96 (+1.13%)

, ESTA

Establishment Labs

$17.06 /

+ (+0.00%)

, DKNG

DraftKings

$25.95 /

+0.09 (+0.35%)

, BILL

Bill.com

$73.00 /

-2.46 (-3.26%)

, OTIS

Otis Worldwide

$47.74 /

-0.51 (-1.06%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX) initiated with a Buy at Jefferies. 2. Establishment Labs (ESTA) initiated with a Neutral at Goldman Sachs. 3. DraftKings (DKNG) initiated with a Positive at Susquehanna. 4. Bill.com (BILL) initiated with a Neutral at Piper Sandler. 5. Otis Worldwide (OTIS) initiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
OTIS Otis Worldwide
$47.74 /

-0.51 (-1.06%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

ESTA Establishment Labs
$17.06 /

+ (+0.00%)

DKNG DraftKings
$25.95 /

+0.09 (+0.35%)

BILL Bill.com
$73.00 /

-2.46 (-3.26%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

05/14/20 Jefferies
Jefferies starts Netflix at Buy, lays out three reasons to own
05/14/20 Jefferies
Netflix initiated with a Buy at Jefferies
05/07/20 Stifel
Stifel boosts price target on 'unstoppable juggernaut' Peloton to $50 from $42
04/29/20 Loop Capital
Netflix price target raised to $500 from $490 at Loop Capital
ESTA Establishment Labs
$17.06 /

+ (+0.00%)

05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
07/12/19 Wells Fargo
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
DKNG DraftKings
$25.95 /

+0.09 (+0.35%)

05/14/20 Craig-Hallum
DraftKings price target raised to $30 from $25 at Craig-Hallum
05/14/20 Susquehanna
DraftKings initiated with a Positive at Susquehanna
05/05/20
Fly Intel: Top five analyst initiations
05/05/20 Canaccord
DraftKings initiated with a Buy at Canaccord
BILL Bill.com
$73.00 /

-2.46 (-3.26%)

05/14/20 Piper Sandler
Bill.com initiated with a Neutral at Piper Sandler
05/08/20 KeyBanc
Bill.com price target raised to $76 from $60 at KeyBanc
05/08/20 Jefferies
Bill.com price target raised to $70 from $45 at Jefferies
05/05/20 KeyBanc
Bill.com price target raised to $60 from $50 at KeyBanc
OTIS Otis Worldwide
$47.74 /

-0.51 (-1.06%)

05/14/20 Credit Suisse
Otis Worldwide initiated with a Neutral at Credit Suisse
05/08/20
Fly Intel: Top analyst initiations
05/08/20 William Blair
Otis Worldwide initiated with a Market Perform at William Blair
04/15/20 Barclays
Otis Worldwide initiated with an Equal Weight at Barclays
OTIS Otis Worldwide
$47.74 /

-0.51 (-1.06%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

ESTA Establishment Labs
$17.06 /

+ (+0.00%)

BILL Bill.com
$73.00 /

-2.46 (-3.26%)

OTIS Otis Worldwide
$47.74 /

-0.51 (-1.06%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

BILL Bill.com
$73.00 /

-2.46 (-3.26%)

OTIS Otis Worldwide
$47.74 /

-0.51 (-1.06%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

DKNG DraftKings
$25.95 /

+0.09 (+0.35%)

BILL Bill.com
$73.00 /

-2.46 (-3.26%)

NFLX Netflix
$443.62 /

+4.96 (+1.13%)

Initiation
Establishment Labs initiated with a Neutral at Goldman Sachs » 05:09
05/14/20
05/14
05:09
05/14/20
05:09
ESTA

Establishment Labs

$17.06 /

-0.93 (-5.17%)

Goldman Sachs analyst…

Goldman Sachs analyst Amit Hazan initiated coverage of Establishment Labs with a Neutral rating and $20 price target. The analyst sees "significant" opportunities for the company to consistently gain share in the $2.2B breast aesthetics market, but caution regarding the COVID-19 pandemic and related financial statement impacts leaves him Neutral rated "for the time being."

ShowHide Related Items >><<
ESTA Establishment Labs
$17.06 /

-0.93 (-5.17%)

ESTA Establishment Labs
$17.06 /

-0.93 (-5.17%)

01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
07/12/19 Wells Fargo
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
07/11/19 Wells Fargo
Market right in seeing rebate news as risk to pharmaceuticals, says Wells Fargo
ESTA Establishment Labs
$17.06 /

-0.93 (-5.17%)

Earnings
Establishment Labs reports Q1 EPS (79c), consensus (31c) » 16:50
05/07/20
05/07
16:50
05/07/20
16:50
ESTA

Establishment Labs

$17.97 /

+0.07 (+0.39%)

Reports Q1 revenue…

Reports Q1 revenue $24.5M, consensus $23.41M. "We are pleased to report that our first quarter sales were $24.5 million - at the higher end of the $23 to $25 million range we projected. This reflects 18% growth over the year ago period as plastic surgeons and their patients continued to adopt Motiva Implants," said Juan Jose Chacon Quiros, Chief Executive Officer of Establishment Labs. "Even though our March sales were measurably impacted by COVID-19, our first quarter still represented another record quarter for our Company, and illustrates the strength and momentum of our product and brands in the market."Despite our long-term bullishness about the breast implant business, we have taken early and decisive steps to prepare our Company to weather these uncertain times. We have reduced our planned 2020 expenses by approximately 20%, while at the same time expanded our business excellence program and invested more in digital platforms. Importantly, Establishment Labs is in a solid financial position and we remain confident in the fundamentals of our business and the strength of our product portfolio, which up until now has resulted in robust year-over-year growth and market share gains," Mr. Chacon Quiros continued.

ShowHide Related Items >><<
ESTA Establishment Labs
$17.97 /

+0.07 (+0.39%)

01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
07/12/19 Wells Fargo
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
07/11/19 Wells Fargo
Market right in seeing rebate news as risk to pharmaceuticals, says Wells Fargo
Over a quarter ago
Conference/Events
Stephens analysts hold an analyst/industry conference call » 12:55
04/16/20
04/16
12:55
04/16/20
12:55
ABMD

Abiomed

$159.25 /

-0.37 (-0.23%)

, ALC

Alcon

$50.51 /

-0.22 (-0.43%)

, AVNS

Avanos

$28.42 /

-0.32 (-1.11%)

, BSX

Boston Scientific

$35.08 /

+0.255 (+0.73%)

, ESTA

Establishment Labs

$14.09 /

+0.18 (+1.29%)

, GKOS

Glaukos

$33.72 /

+0.255 (+0.76%)

, SIEN

Sientra

$1.75 /

+ (+0.00%)

, STE

Steris

$151.40 /

-3.31 (-2.14%)

, STAA

Staar Surgical

$35.75 /

-0.29 (-0.80%)

, TFX

Teleflex

$327.84 /

-2.73 (-0.83%)

, EHC

Encompass Health

$68.94 /

-0.82 (-1.18%)

, HCA

HCA Healthcare

$108.25 /

-1.28 (-1.17%)

, THC

Tenet

$18.84 /

-0.68 (-3.48%)

, UNH

UnitedHealth

$290.00 /

+8.23 (+2.92%)

, UHS

Universal Health

$100.27 /

-2.72 (-2.64%)

Analysts, along with…

Analysts, along with Darin Hill, CEO of Compass Surgical Partners, hold an Analyst/Industry conference call on April 16 at 1:30 pm.

ShowHide Related Items >><<
ABMD Abiomed
$159.25 /

-0.37 (-0.23%)

03/23/20 Piper Sandler
Abiomed's Impella may play role in treating COVID-19, says Piper Sandler
02/12/20
Fly Intel: Top five analyst downgrades
02/12/20 Morgan Stanley
Abiomed downgraded to Underweight on Impella pressures at Morgan Stanley
02/12/20 Piper Sandler
Abiomed risk/reward attractive for longer term investors, says Piper Sandler
ALC Alcon
$50.51 /

-0.22 (-0.43%)

04/09/20 Wells Fargo
Alcon price target lowered to $58 from $70 at Wells Fargo
04/08/20 Baird
Alcon downgraded to Neutral at Baird
04/08/20 Baird
Alcon downgraded to Neutral from Outperform at Baird
03/26/20 Argus
Alcon upgraded to Buy from Hold at Argus
AVNS Avanos
$28.42 /

-0.32 (-1.11%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
11/06/19 Stifel
Avanos downgraded to Hold from Buy at Stifel
11/06/19 Stifel
Avanos downgraded to Hold from Buy at Stifel
BSX Boston Scientific
$35.08 /

+0.255 (+0.73%)

04/09/20 Raymond James
Boston Scientific price target lowered to $42 from $49 at Raymond James
04/02/20 Piper Sandler
Piper reiterates Overweight rating on Boston Scientific, sees bounce back coming
04/01/20 Goldman Sachs
Boston Scientific upgraded to Conviction Buy from Neutral at Goldman Sachs
03/30/20 Piper Sandler
Boston Scientific will bounce back well post COVID-19, says Piper Sandler
ESTA Establishment Labs
$14.09 /

+0.18 (+1.29%)

01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
07/12/19 Wells Fargo
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
07/11/19 Wells Fargo
Market right in seeing rebate news as risk to pharmaceuticals, says Wells Fargo
GKOS Glaukos
$33.72 /

+0.255 (+0.76%)

04/09/20 Piper Sandler
Glaukos longer term fundamentals 'fully intact,' says Piper Sandler
04/08/20 Wells Fargo
Glaukos price target lowered to $34 from $53 at Wells Fargo
03/24/20 Piper Sandler
Glaukos longer-term fundamentals fully intact, says Piper Sandler
03/04/20 Citi
Glaukos initiated with a Sell at Citi
SIEN Sientra
$1.75 /

+ (+0.00%)

03/12/20 Craig-Hallum
Sientra price target lowered to $9 from $14 at Craig-Hallum
03/12/20 SVB Leerink
Sientra price target lowered to $6.50 from $13 at SVB Leerink
03/12/20 Maxim
Sientra price target lowered to $8 from $12 at Maxim
03/12/20 Canaccord
Sientra price target lowered to $9 from $13 at Canaccord
STE Steris
$151.40 /

-3.31 (-2.14%)

07/10/19 KeyBanc
Steris downgraded to Sector Weight on valuation at KeyBanc
07/09/19 KeyBanc
STERIS downgraded to Sector Weight from Overweight at KeyBanc
05/15/19 Stephens
STERIS price target raised to $150 from $135 at Stephens
STAA Staar Surgical
$35.75 /

-0.29 (-0.80%)

03/04/20
BTIG healthcare analysts to hold an analyst/industry conference call
01/31/20 Benchmark
Too early to call China emergency impact on Staar Surgical, says Benchmark
01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
TFX Teleflex
$327.84 /

-2.73 (-0.83%)

04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
10/31/19 Piper Sandler
Urolift driving majority of Teleflex earnings beat, says Piper Jaffray
EHC Encompass Health
$68.94 /

-0.82 (-1.18%)

03/06/20 Deutsche Bank
Encompass Health price target raised to $83 from $73 at Deutsche Bank
03/05/20 BMO Capital
Encompass Health price target raised to $95 from $88 at BMO Capital
03/05/20 Baird
Encompass Health price target raised to $100 from $85 at Baird
03/05/20 Stephens
Encompass Health price target raised to $100 from $91 at Stephens
HCA HCA Healthcare
$108.25 /

-1.28 (-1.17%)

03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
02/03/20 Barclays
HCA Healthcare price target raised to $177 from $172 at Barclays
01/29/20 SunTrust
HCA Healthcare price target raised to $185 from $175 at SunTrust
01/29/20 Oppenheimer
HCA Healthcare price target raised to $160 from $155 at Oppenheimer
THC Tenet
$18.84 /

-0.68 (-3.48%)

04/03/20 SunTrust
Tenet price target lowered to $18 from $42 at SunTrust
03/11/20 RBC Capital
Tenet upgraded to Outperform from Sector Perform at RBC Capital
02/26/20
Fly Intel: Top five analyst upgrades
UNH UnitedHealth
$290.00 /

+8.23 (+2.92%)

04/16/20 Raymond James
UnitedHealth price target lowered to $325 from $340 at Raymond James
04/16/20 Credit Suisse
UnitedHealth price target lowered to $325 from $330 at Credit Suisse
04/16/20 Cowen
UnitedHealth price target lowered to $320 from $340 at Cowen
04/09/20 Cleveland Research
UnitedHealth existing 2020 guidance looks achievable, says Cleveland Research
UHS Universal Health
$100.27 /

-2.72 (-2.64%)

03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
03/23/20 BofA
Universal Health downgraded to Neutral from Buy at BofA
01/07/20 BofA
Universal Health named top 2020 Health Care Facilities pick at BofA

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.